Main
>
ONCOLOGY (**)
>
Breast Cancer>HER2+>Adjuvant ***
>
USA. G. PertuzuMAb+TrastuzuMAb+ SC
>
(*) EU CE Mark Date: 2020. 12.23.
(*) EU CE Mark Date: 2020. 12.23.'s products
This section has no products